Should Investors Consider Selling Teladoc Stock?
Despite its leadership in the global telehealth space and quarter after quarter of strong growth, shares of Teladoc (NYSE: TDOC) have fallen by over 60% in the trailing 12 months. Should investors give up or is this just a sign of the broader market volatility? In this segment of Backstage Pass recorded on Dec. 22, Fool contributor Rachel Warren shares her personal take as a Teladoc shareholder.
Source Fool.com
